Skip to main content
Beijing Strong Biotechnologies, Inc logo

Beijing Strong Biotechnologies, Inc — Investor Relations & Filings

Ticker · 300406 ISIN · CNE100001Y26 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,957 across all filing types
Latest filing 2026-05-25 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300406

About Beijing Strong Biotechnologies, Inc

https://www.bsbe.com.cn

Beijing Strong Biotechnologies, Inc. (BSBE) specializes in the research, development, manufacture, and distribution of in vitro diagnostic (IVD) products. The company’s core portfolio includes a comprehensive range of clinical chemistry reagents, such as those for liver and kidney function, lipid profiles, and cardiovascular markers. BSBE also develops automated diagnostic instruments, including chemiluminescence immunoassay systems and coagulation analyzers. The company is recognized for its commitment to standardization and quality control, providing reference materials and participating in international traceability initiatives. Its products serve clinical laboratories, hospitals, and medical institutions, supported by strategic collaborations with global diagnostic leaders to enhance laboratory efficiency and diagnostic accuracy.

Recent filings

Filing Released Lang Actions
关于公司获得发明专利证书的公告
Regulatory Filings Classification · 91% confidence The document is a public announcement (“公告”) by the company’s board notifying investors of newly granted invention patent certificates. It contains no financials, management changes, voting results, or dividend/financing details. It is a routine regulatory disclosure rather than a financial report or a specialized governance or M&A document. Therefore it falls under the general regulatory announcement category.
2026-05-25 Chinese
2025年年度权益分派实施公告
Notice of Dividend Amount Classification · 90% confidence The document is a detailed announcement of the company’s 2025 annual profit distribution (“权益分派实施公告”) including dividend amount per ten shares, total cash dividend, record date, ex-dividend date, payment method, and related procedures. It is a dividend notice rather than a full financial report or regulatory filing. Therefore, it should be classified as a Notice of Dividend Amount (DIV).
2026-05-21 Chinese
关于九强转债转股价格调整的公告
Capital/Financing Update Classification · 92% confidence The document is an official announcement by Beijing Jiuqiang Biotech regarding the adjustment of the conversion price for its outstanding convertible bonds (“九强转债”). It provides detailed reasoning, formulas, and results for the price change. This relates to a financing instrument and a change in capital structure rather than issuance of a full financial report or proxy materials. Therefore, it best fits the “Capital/Financing Update” category.
2026-05-21 Chinese
关于实施权益分派期间“九强转债”暂停转股的提示性公告
Regulatory Filings
2026-05-19 Chinese
北京联慧律师事务所关于北京九强生物技术股份有限公司2025年年度股东会之法律意见书
Regulatory Filings Classification · 80% confidence The document is a legal opinion (法律意见书) issued by an external law firm regarding the convening, attendance qualifications, voting procedures, and voting results of the 2025 Annual General Meeting. It is not the AGM presentation materials themselves (AGM-R), nor is it simply a short announcement of voting results (DVA), but rather a compliance/legal opinion letter. Under the Certification Rule and fallback guidelines, standalone legal opinion letters or attestations filed with regulators are classified as a Regulatory Filing (RNS).
2026-05-18 Chinese
2025年年度股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a formal announcement of the results of shareholder votes at the 2025 Annual General Meeting of Beijing Jiuliang Bio Technology Co., Ltd. It details meeting attendance, each resolution voted on, and the voting outcomes. This matches the definition of “Declaration of Voting Results & Voting Rights Announcements” (code DVA).
2026-05-18 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.